Trump to announce pharma tariffs soon

U.S. President Donald Trump said on Friday that he would soon announce tariffs targeting the pharmaceutical industry but did not provide details on timing or rates.

Speaking to reporters aboard Air Force One, Trump also stated that he was open to negotiating deals with countries seeking to avoid U.S. tariffs, but such agreements would have to come after his administration announces reciprocal tariffs on April 2.

Countries including Britain have approached the U.S. to discuss potential deals, Trump said.

“They want to make deals. It’s possible if we can get something for the deal,” he noted. However, when asked if these deals could happen before April 2, he ruled it out, saying, “No, probably later. It’s a process.”

Earlier, President Trump announced a 25% tariff on auto imports, claiming it would boost domestic manufacturing. The White House expects the move to generate $100 billion annually, but it could strain automakers reliant on global supply chains.

The tariffs, set to take effect in April, may raise costs and lower sales, though Trump insists they will lead to more U.S. factories.

Declaring the decision “permanent,” he also warned the EU and Canada of even higher tariffs if they coordinate against the U.S.

Related Posts

Minister JP Nadda launches drug registry to standardise medicine-related information

Union minister of health and family welfare, Jagat Prakash Nadda launched the Drug Registry as a unified and standardised digital platform for drug-related information to address the issues including confusion…

Pharmexcil urges companies to adopt NCB voluntary code to prevent chemical diversion into illegal drug production

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged its member pharma companies to implement the Voluntary Code of Conduct (VCC) introduced by the Narcotics Control Bureau (NCB) to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Minister JP Nadda launches drug registry to standardise medicine-related information

Minister JP Nadda launches drug registry to standardise medicine-related information

Pharmexcil urges companies to adopt NCB voluntary code to prevent chemical diversion into illegal drug production

Pharmexcil urges companies to adopt NCB voluntary code to prevent chemical diversion into illegal drug production

Govt review finds no common thread in post-delivery deaths

Gurgaon call centre busted for cheating people with fake weight-loss products, 3 women held

Gurgaon call centre busted for cheating people with fake weight-loss products, 3 women held

Madhya Pradesh toddler loses vision after doctor administers drops, probe underway

Madhya Pradesh toddler loses vision after doctor administers drops, probe underway

CDSCO Mandates SUGAM Portal for Post-Approval Changes (PAC) to Vaccine and Anti-Sera Import Licences

CDSCO Mandates SUGAM Portal for Post-Approval Changes (PAC) to Vaccine and Anti-Sera Import Licences